9.22BINR
Type
Common Stock
Exchange
NSE
Currency Code
INR
Currency Name
Indian Rupee
Country Name
India
Country ISO
IN
ISIN
INE010B01027
CUSIP
-
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
March
IPO date
-
Updated At
-
PE Ratio
21.37
PEG Ratio
-
Book Value
251.49
Dividend Share
1
Dividend Yield
0.09%
Earnings Share
50.11
Wall Street Target Price
1,066.50
EPS Estimate Current Year
45.16
EPS Estimate Next Year
41.81
EPS Estimate Current Quarter
9.2973
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
271,483,994,112
Gross Profit TTM
198,558,007,296
EBITDA
72,576,000,000
Profit Margin
18.57%
Return On Assets TTM
8.07%
Return On Equity TTM
18.32%
Revenue Per Share TTM
269.814
Qtly Revenue Growth YOY
16.20%
Diluted Eps TTM
50.11
Qtly Earnings Growth YOY
8.70%
Trailing PE
21.37
Forward PE
14
Price Sales TTM
3.9344
Price Book MRQ
3.9398
Enterprise Value Revenue
4
Enterprise Value EBITDA
13
1415.70
4.73%1291.05
1.53%1863.45
1.43%4457.75
0.70%6787.50
0.66%6784.95
0.65%4457.00
0.61%2339.45
-0.53%2340.00
-0.49%1491.90
-0.39%